LOS ANGELES, CA--(Marketwired - Apr 24, 2014) - MMRGlobal, Inc. (OTCQB: MMRF) ("MMR") today announced that its patented MyMedicalRecords Personal Health Record (PHR) is now being sold in medical cannabis dispensaries. The Company's wholly owned subsidiary, MyMedicalRecords, Inc., launched its program of selling PHRs through dispensaries after months of testing various marketing and sales incentive programs. MyMedicalRecords also has plans to license its patented PHR technologies to others in the cannabis space who may be offering products that infringe on the Company's MyMedicalRecords patents and other intellectual property.

Every password-protected MyMedicalRecords account includes four MyEsafeDepositBox file folders with additional layers of security that can be used to give medical cannabis patients a private and safe place to store encrypted copies of physician recommendations and/or prescriptions. These folders allow patients to protect their sensitive medical information from unauthorized access or view. MyMedicalRecords keeps a user's most personal, private information pertaining to cannabis usage from employer and government intrusiveness as well as any others who might inadvertently view private medical records or cannabis recommendations in a home or office file. This could be particularly damaging to patients who use medical cannabis to navigate through significant health issues; for example, glaucoma patients taking medical cannabis to better manage the effects of reduced intraocular pressure, or patients experiencing side effects from chemotherapy, as well as those who are prescribed it for pain management from fibromyalgia or non-specific neuropathy, among other conditions. Damages from corporate intrusion into an employee's legitimate medical issues can be partially avoided by using a secure MyMedicalRecords PHR.

Another valuable feature of using a MyMedicalRecords PHR is the ability for individuals to prove they indeed have a prescription by carrying an encrypted copy in their MyMedicalRecords account on their smartphone to have whenever and wherever it's needed including to display to law enforcement officers should the need arise. MMR has created a complete program for cannabis retailers including customized point-of-sale displays with built-in systems designed to incentivize employees and customers through frequent purchase incentives, communicate and distribute newsletters, and conduct market research. Try a MyMedicalRecords PHR for free at www.mymedicalrecords.com.

MMRGlobal is a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions and MMRPro document management and imaging systems for healthcare professionals. The use of Personal Health Records is a key part of modernizing America's healthcare system and the government is spending hundreds of millions of dollars in education designed to empower patients to take greater control of their health, using tools such as a PHR.

About MMRGlobal
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. MMR's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, MMR acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of MMR's products and services at www.mmrtheater.com. Follow us at Facebook.com/MMRGlobal and Twitter.com/mmrglobal.

Forward-Looking Statements
Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue." Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. The information discussed in this release is subject to various risks and uncertainties related to the Company's business prospects, results of operations or financial condition; the risk our products and services are not adopted or viewed favorably by the healthcare community and consumer retail markets; unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both MMR's health IT and biotechnology intellectual property assets in the U.S. and internationally; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; marketing promotions and campaigns; product integration in physician practices and hospitals; timing and volume of sales and installations; length of sales cycles and the installation process; programs and initiatives; ability to establish and maintain strategic relationships; competitive product offerings and promotions; maintaining, developing and defending our intellectual property rights; marketing and exploitation of our patent portfolio; government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; legal, regulatory, and other circumstances and conditions in the cannabis industry; and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.'s public filings with the U.S. Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Contact Information:


Michael Selsman
Public Communications Co.
(310) 922-7033